Evidence map›Paper›PMID 24033914›Full record

ArticleJournal of pineal research2013

Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.

Dongxia Ge, Robert T Dauchy, Sen Liu, Qiuyang Zhang, Lulu Mao, Erin M Dauchy, David E Blask, Steven M Hill, Brian G Rowan, George C Brainard and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of pineal research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bioinformatics Based Therapeutic Effects of Sinomenium Acutum.Chinese journal of integrative medicine · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Stressed and Inflamed, Can GSK3 Be Blamed?Trends in biochemical sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Dongxia GeDepartment of Structural & Cellular Biology, Tulane University Health Sciences Center, New Orleans, LA, USA.
Robert T Dauchy
Sen Liu
Qiuyang Zhang
Lulu Mao
Erin M Dauchy
David E Blask
Steven M Hill
Brian G Rowan
George C Brainard
John P Hanifin
Kate S Cecil
Zhenggang Xiong
Leann Myers
Zongbing You
Tulane University · USThomas Jefferson University · US

Funding

UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBPP20RR020152 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2004 to 2011
$17.0M
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
The role of IL-17 in prostate cancerR01CA174714 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI YOU, ZONGBING · 2013 to 2017
$1.6M
Melatonin Supplementation in Complementary Breast Cancer PreventionR21CA129875 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI BLASK, DAVID · 2008 to 2011
$497k
NCI NIH HHS 1R21CA129875-01A1NCI NIH HHS R01 CA174714NCI NIH HHS R01CA174714NCI NIH HHS R21 CA129875NCRR NIH HHS P20 RR020152NIGMS NIH HHS 8P20GM103518-09NIGMS NIH HHS P20 GM103518
6 · The paper itself

Abstract

Obesity is a chronic inflammation with increased serum levels of insulin, insulin-like growth factor 1 (IGF1), and interleukin-17 (IL-17). The objective of this study was to test a hypothesis that insulin and IGF1 enhance IL-17-induced expression of inflammatory chemokines/cytokines through a glycogen synthase kinase 3β (GSK3B)-dependent mechanism, which can be inhibited by melatonin. We found that insulin/IGF1 and lithium chloride enhanced IL-17-induced expression of C-X-C motif ligand 1 (Cxcl1) and C-C motif ligand 20 (Ccl20) in the Gsk3b(+/+) , but not in Gsk3b(-/-) mouse embryonic fibroblast (MEF) cells. IL-17 induced higher levels of Cxcl1 and Ccl20 in the Gsk3b(-/-) MEF cells, compared with the Gsk3b(+/+) MEF cells. Insulin and IGF1 activated Akt to phosphorylate GSK3B at serine 9, thus inhibiting GSK3B activity. Melatonin inhibited Akt activation, thus decreasing P-GSK3B at serine 9 (i.e., increasing GSK3B activity) and subsequently inhibiting expression of Cxcl1 and Ccl20 that was induced either by IL-17 alone or by a combination of insulin and IL-17. Melatonin's inhibitory effects were only observed in the Gsk3b(+/+) , but in not Gsk3b(-/-) MEF cells. Melatonin also inhibited expression of Cxcl1, Ccl20, and Il-6 that was induced by a combination of insulin and IL-17 in the mouse prostatic tissues. Further, nighttime human blood, which contained high physiologic levels of melatonin, decreased expression of Cxcl1, Ccl20, and Il-6 in the PC3 human prostate cancer xenograft tumors. Our data support our hypothesis and suggest that melatonin may be used to dampen IL-17-mediated inflammation that is enhanced by the increased levels of insulin and IGF1 in obesity.

Indexed as

AnimalsBlotting, WesternCell Line, TumorGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansInsulinInsulin-Like Growth Factor IInterleukin-17Lithium ChlorideMelatoninMiceMice, KnockoutPhosphorylationReverse Transcriptase Polymerase Chain ReactionSignal TransductionGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanGsk3b protein, mouseInsulinInsulin-Like Growth Factor IInterleukin-17Lithium ChlorideMelatoninglycogen synthase kinase 3βinflammationinsulininsulin-like growth factor 1interleukin-17melatoninprostate cancer

Identifiers

PMID24033914
PMCPMC3797167
OpenAlexW2008894693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.